Diabetes management startup Health2Sync raised $3 million in a Series A round, which it will use toward product development and to drive growth in markets…

Patients who have been diagnosed paraplegic could show long-term positive results in mobility thanks to interesting therapy partners: robots and brain machine…

The FDA awarded ImPACT Applications de novo clearance for two new devices to evaluate a patient’s cognitive function following a suspected brain injury or…

Singlera Genomics, which is developing noninvasive genetic tests, raised $20 million in a Series A round. It will use the funding to boost its R&D…

Foundation Medicine announced new clinical markers to its FoundationOne and FoundationOne Heme products. Using FoundationOne and FoundationOne Heme assays,…

Israel’s Microbot Medical and U.S. biotech StemCells announced Tuesday that they are pursuing a merger to develop robotics-based medical devices.

Presbia announced the completion of the purchase of Neoptics AG’s assets, including its intellectual property portfolio.

While some laboratories are working on minimally invasive hydrogel treatments for heart failure, researchers from the University of Pennsylvania are going a…